Clearline Capital’s Exelixis EXEL Stock Holding History

Clearline Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,939	Closed	-$247K	–	130
2023 Q2	$247K	Hold	12,939	–	–	0.01%	111
2023 Q1	$251K	Buy	+12,939	New	+$225K	0.04%	99

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Clearline Capital's EXEL Position: Q3 2023 in Review

Clearline Capital sold out of Exelixis (EXEL) in Q3 2023, closing a stake of 12,939 shares — an estimated $247K sold.

Clearline Capital first reported a position in EXEL in Q1 2023 and held it in 2 quarters. The position peaked at $251K in Q1 2023. 397 funds tracked by Wall St. Rank hold EXEL as of Q3 2023.

Clearline Capital reported no remaining Exelixis position as of Q3 2023 after selling out during the quarter.
Clearline Capital sold 12,939 Exelixis shares in Q3 2023, an estimated $247K.
Clearline Capital first reported a position in Exelixis in Q1 2023 and held it in 2 quarters.
Clearline Capital's Exelixis position peaked at $251K in Q1 2023.
397 funds tracked by Wall St. Rank held Exelixis as of Q3 2023.

Based on Clearline Capital's 13F filing for Q3 2023, filed 14 Nov 2023.